On future non-medical costs in economic evaluations
(2008) In Health Economics 17(5). p.579-591- Abstract
- Economic evaluation in health care is still an evolving discipline. One of the current controversies in cost-effectiveness analysis regards the inclusion or exclusion of future non-medical costs (i.e. consumption net of production) due to increased survival. This paper examines the implications of a symmetry rule stating that there should be consistency between costs included in the numerator and utility aspects included in the denominator. While the observation that no quality-adjusted lire year (QALY) instruments explicitly include consumption and leisure seems to give support to the notion that future non-medical costs should be excluded when QALYs are used as the outcome measure, a better understanding of what respondents actually... (More)
- Economic evaluation in health care is still an evolving discipline. One of the current controversies in cost-effectiveness analysis regards the inclusion or exclusion of future non-medical costs (i.e. consumption net of production) due to increased survival. This paper examines the implications of a symmetry rule stating that there should be consistency between costs included in the numerator and utility aspects included in the denominator. While the observation that no quality-adjusted lire year (QALY) instruments explicitly include consumption and leisure seems to give support to the notion that future non-medical costs should be excluded when QALYs are used as the outcome measure, a better understanding of what respondents actually consider when reporting QALY weights is required. However, the more fundamental question is whether QALYs can be interpreted as utilities. Or more precisely, what are the assumptions needed for a general utility model also including consumption and leisure to be consistent with QALYs? Once those assumptions are identified, they need to be experimentally tested to see whether they are at least approximately valid. Until we have answers to these areas for future research, it seems premature to include future non-medical costs. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1201738
- author
- Liljas, Bengt LU ; Karlsson, Göran S and Stålhammar, Nils-Olov
- organization
- publishing date
- 2008
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- QALYs, welfare economics, cost-effectiveness analysis, economic evaluation, future costs
- in
- Health Economics
- volume
- 17
- issue
- 5
- pages
- 579 - 591
- publisher
- John Wiley & Sons Inc.
- external identifiers
-
- wos:000256249500002
- scopus:44649183389
- ISSN
- 1099-1050
- DOI
- 10.1002/hec.1279
- language
- English
- LU publication?
- yes
- additional info
- The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Lund University Centre for Health Economics (LUCHE) (016630120), Department of Economics (012008000)
- id
- 450165ce-d2cb-48b0-8873-801bb8fac8f8 (old id 1201738)
- date added to LUP
- 2016-04-01 11:56:07
- date last changed
- 2022-01-26 20:21:47
@article{450165ce-d2cb-48b0-8873-801bb8fac8f8, abstract = {{Economic evaluation in health care is still an evolving discipline. One of the current controversies in cost-effectiveness analysis regards the inclusion or exclusion of future non-medical costs (i.e. consumption net of production) due to increased survival. This paper examines the implications of a symmetry rule stating that there should be consistency between costs included in the numerator and utility aspects included in the denominator. While the observation that no quality-adjusted lire year (QALY) instruments explicitly include consumption and leisure seems to give support to the notion that future non-medical costs should be excluded when QALYs are used as the outcome measure, a better understanding of what respondents actually consider when reporting QALY weights is required. However, the more fundamental question is whether QALYs can be interpreted as utilities. Or more precisely, what are the assumptions needed for a general utility model also including consumption and leisure to be consistent with QALYs? Once those assumptions are identified, they need to be experimentally tested to see whether they are at least approximately valid. Until we have answers to these areas for future research, it seems premature to include future non-medical costs.}}, author = {{Liljas, Bengt and Karlsson, Göran S and Stålhammar, Nils-Olov}}, issn = {{1099-1050}}, keywords = {{QALYs; welfare economics; cost-effectiveness analysis; economic evaluation; future costs}}, language = {{eng}}, number = {{5}}, pages = {{579--591}}, publisher = {{John Wiley & Sons Inc.}}, series = {{Health Economics}}, title = {{On future non-medical costs in economic evaluations}}, url = {{http://dx.doi.org/10.1002/hec.1279}}, doi = {{10.1002/hec.1279}}, volume = {{17}}, year = {{2008}}, }